MX2007008379A - Metodos y composiciones para minimizar la acumulacion de insulina inhlable en los pulmones. - Google Patents
Metodos y composiciones para minimizar la acumulacion de insulina inhlable en los pulmones.Info
- Publication number
- MX2007008379A MX2007008379A MX2007008379A MX2007008379A MX2007008379A MX 2007008379 A MX2007008379 A MX 2007008379A MX 2007008379 A MX2007008379 A MX 2007008379A MX 2007008379 A MX2007008379 A MX 2007008379A MX 2007008379 A MX2007008379 A MX 2007008379A
- Authority
- MX
- Mexico
- Prior art keywords
- accrual
- lungs
- minimizing
- methods
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Abstract
Se proveen composiciones de insulina inhalable que se eliminan rapidamente de los pulmones de los pacientes. Adicionalmente se describen metodo para minimizar la acumulacion de insulina despues de la administracion de una composicion de insulina inhalada.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64305405P | 2005-01-10 | 2005-01-10 | |
PCT/US2006/000910 WO2006086107A2 (en) | 2005-01-10 | 2006-01-10 | Methods and compositions for minimizing accrual of inhalable insulin in the lungs |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007008379A true MX2007008379A (es) | 2008-02-19 |
Family
ID=36793549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007008379A MX2007008379A (es) | 2005-01-10 | 2006-01-10 | Metodos y composiciones para minimizar la acumulacion de insulina inhlable en los pulmones. |
Country Status (7)
Country | Link |
---|---|
US (1) | US20060153778A1 (es) |
EP (1) | EP1858486A2 (es) |
JP (1) | JP2008526893A (es) |
AU (1) | AU2006213084A1 (es) |
CA (1) | CA2592776A1 (es) |
MX (1) | MX2007008379A (es) |
WO (1) | WO2006086107A2 (es) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU779986B2 (en) | 1999-06-29 | 2005-02-24 | Mannkind Corporation | Purification and stabilization of peptide and protein pharmaceutical agents |
US9006175B2 (en) * | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
ES2300568T3 (es) | 2002-03-20 | 2008-06-16 | Mannkind Corporation | Aparato de inhalacion. |
US9078866B2 (en) * | 2003-08-01 | 2015-07-14 | Mannkind Corporation | Method for treating hyperglycemia with GLP-1 |
US20070027063A1 (en) * | 2004-01-12 | 2007-02-01 | Mannkind Corporation | Method of preserving the function of insulin-producing cells |
MX2007001903A (es) | 2004-08-20 | 2007-08-02 | Mannkind Corp | Catalisis de sintesis de dicetopiperazina. |
KR101306384B1 (ko) | 2004-08-23 | 2013-09-09 | 맨카인드 코포레이션 | 약물 전달용 디케토피페라진염, 디케토모르포린염 또는디케토디옥산염 |
AU2014271222B2 (en) * | 2005-09-14 | 2016-04-28 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
JP5465878B2 (ja) | 2005-09-14 | 2014-04-09 | マンカインド コーポレイション | 活性薬剤に対する結晶性微粒子表面の親和性を増大させることに基づく薬物処方の方法 |
CN104383546B (zh) | 2006-02-22 | 2021-03-02 | 曼金德公司 | 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法 |
US8785396B2 (en) | 2007-10-24 | 2014-07-22 | Mannkind Corporation | Method and composition for treating migraines |
MX2010004510A (es) * | 2007-10-24 | 2010-07-02 | Mannkind Corp | Metodo para prevenir los efectos nocivos de peptido 1 tipo glucagon (glp-1). |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
CN104689432B (zh) | 2008-06-13 | 2018-07-06 | 曼金德公司 | 干粉吸入器和用于药物输送的系统 |
US20190262557A1 (en) * | 2010-03-04 | 2019-08-29 | Mannkind Corporation | Dry powder drug delivery system |
JP5479465B2 (ja) | 2008-06-20 | 2014-04-23 | マンカインド コーポレイション | 吸入努力をリアルタイムにプロファイルする対話式機器および方法 |
TWI494123B (zh) * | 2008-08-11 | 2015-08-01 | Mannkind Corp | 超快起作用胰島素之用途 |
US11110151B2 (en) * | 2008-08-11 | 2021-09-07 | Mannkind Corporation | Composition and method for reducing hypoglycemia events in diabetes treatment |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
AU2014200960B2 (en) * | 2009-03-04 | 2016-02-11 | Mannkind Corporation | An improved dry powder drug delivery system |
CA2791847C (en) * | 2009-03-04 | 2017-05-02 | Mannkind Corporation | An improved dry powder drug delivery system |
PL2405963T3 (pl) | 2009-03-11 | 2014-04-30 | Mannkind Corp | Urządzenie, układ i sposób pomiaru oporu inhalatora |
MY172858A (en) * | 2009-06-12 | 2019-12-12 | Mannkind Corp | Diketopiperazine microparticles with defined isomer contents |
EP2440184B1 (en) * | 2009-06-12 | 2023-04-05 | MannKind Corporation | Diketopiperazine microparticles with defined specific surface areas |
WO2011056889A1 (en) | 2009-11-03 | 2011-05-12 | Mannkind Corporation | An apparatus and method for simulating inhalation efforts |
RU2571331C1 (ru) | 2010-06-21 | 2015-12-20 | Маннкайнд Корпорейшн | Системы и способы доставки сухих порошковых лекарств |
DK2694402T3 (en) | 2011-04-01 | 2017-07-03 | Mannkind Corp | BLISTER PACKAGE FOR PHARMACEUTICAL CYLINDER AMPULS |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
AU2012328885B2 (en) | 2011-10-24 | 2017-08-31 | Mannkind Corporation | Methods and compositions for treating pain |
AU2013289957B2 (en) | 2012-07-12 | 2017-02-23 | Mannkind Corporation | Dry powder drug delivery systems and methods |
WO2014066856A1 (en) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Inhalable influenza vaccine compositions and methods |
EP3587404B1 (en) | 2013-03-15 | 2022-07-13 | MannKind Corporation | Microcrystalline diketopiperazine compositions, methods for preparation and use thereof |
BR112016000937A8 (pt) | 2013-07-18 | 2021-06-22 | Mannkind Corp | formulações farmacêuticas de pó seco, método para a fabricação de uma formulação de pó seco e uso de uma formulação farmacêutica de pó seco |
JP2016530930A (ja) | 2013-08-05 | 2016-10-06 | マンカインド コーポレイション | 通気装置及び方法 |
WO2015148905A1 (en) | 2014-03-28 | 2015-10-01 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2000301A (en) * | 1932-04-02 | 1935-05-07 | Norman Confections Inc | Progressive container |
US5352461A (en) * | 1992-03-11 | 1994-10-04 | Pharmaceutical Discovery Corporation | Self assembling diketopiperazine drug delivery system |
US5888477A (en) * | 1993-01-29 | 1999-03-30 | Aradigm Corporation | Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin |
US5547929A (en) * | 1994-09-12 | 1996-08-20 | Eli Lilly And Company | Insulin analog formulations |
US6428771B1 (en) * | 1995-05-15 | 2002-08-06 | Pharmaceutical Discovery Corporation | Method for drug delivery to the pulmonary system |
AU779986B2 (en) * | 1999-06-29 | 2005-02-24 | Mannkind Corporation | Purification and stabilization of peptide and protein pharmaceutical agents |
JP2007517892A (ja) * | 2004-01-12 | 2007-07-05 | マンカインド コーポレイション | 2型糖尿病における血清プロインスリンレベルを低下させる方法 |
-
2006
- 2006-01-10 JP JP2007550575A patent/JP2008526893A/ja not_active Withdrawn
- 2006-01-10 CA CA002592776A patent/CA2592776A1/en not_active Abandoned
- 2006-01-10 WO PCT/US2006/000910 patent/WO2006086107A2/en active Application Filing
- 2006-01-10 MX MX2007008379A patent/MX2007008379A/es unknown
- 2006-01-10 AU AU2006213084A patent/AU2006213084A1/en not_active Abandoned
- 2006-01-10 EP EP06748159A patent/EP1858486A2/en not_active Withdrawn
- 2006-01-10 US US11/330,427 patent/US20060153778A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2592776A1 (en) | 2006-08-17 |
WO2006086107A2 (en) | 2006-08-17 |
WO2006086107A3 (en) | 2006-11-23 |
JP2008526893A (ja) | 2008-07-24 |
EP1858486A2 (en) | 2007-11-28 |
AU2006213084A1 (en) | 2006-08-17 |
US20060153778A1 (en) | 2006-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007008379A (es) | Metodos y composiciones para minimizar la acumulacion de insulina inhlable en los pulmones. | |
WO2007149406A3 (en) | Modified coagulation factor ix polypeptides and use thereof for treatment | |
IL260127B (en) | mek inhibitors and methods of using them | |
MX2010002498A (es) | Metodos para tratar o prevenir la infeccion del tracto respiratorio que comprende la administracion de colecalciferol. | |
NO20071505L (no) | Fremgangsmate for sammensetting av legemiddelavgivelsesanordninger. | |
TW200612987A (en) | Combination treatment for non-hematologic malignancies | |
WO2006138608A3 (en) | Pharmaceutical compositions and use thereof | |
UA98839C2 (en) | N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors | |
EP2007398A4 (en) | HIGH ADMINISTRATION SPEEDS FOR LIPID DRUG PREPARATIONS AND METHODS OF TREATMENT THEREOF | |
TW200745078A (en) | Isoindole-imide compounds and compositions comprising and methods of using the same | |
EP2056818A4 (en) | COMPOSITIONS AND METHODS FOR NEUROPROTECTION | |
MX2009010977A (es) | Metodos de administracion de tetrahidrobiopterina, composiciones asociadas y metodos de medicion. | |
MX2009011359A (es) | Derivados de pirimidinona y sus metodos de uso. | |
UA92000C2 (en) | 1-benzylindole-2-carboxamide derivatives | |
EP1926520A4 (en) | APPARATUSES AND METHODS FOR IMPLANTING OBJECTS, SUCH AS BRONCHOSCOPIC IMPLANTATION MARKERS, IN PATIENT LUNGS | |
WO2008063341A3 (en) | Dual action, inhaled formulations providing both an immediate and sustained release profile | |
TW200630105A (en) | Herbal composition PHY906 and its use in chemotherapy | |
WO2005079867A3 (en) | Alpha-emitting hydroxyapatite particles | |
DE602007010764D1 (en) | Benzamidglucokinaseaktivatoren | |
UA98136C2 (ru) | Применение аклидиния для лечения респираторных заболеваний | |
CY1115725T1 (el) | Ενωσεις, συνθεσεις και μεθοδοι για την θεραπευτικη αγωγη των βητα-αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων | |
WO2007133796A3 (en) | Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist | |
PL1610787T3 (pl) | Synergiczna kombinacja zawierająca roflumilast i środek antycholinergiczny wybrany z soli tiotropium do leczenia chorób układu oddechowego | |
MX2015009891A (es) | Composiciones farmaceuticas que comprenden particulas cristalinas de multicomponentes adecuadas para usar en terapia de inhalacion. | |
MY144714A (en) | Treatment of bacterial diseases of the respiratory organs |